logo
UN head 'appalled' by reports of deaths of Palestinians while seeking food aid

UN head 'appalled' by reports of deaths of Palestinians while seeking food aid

Yahoo2 days ago

The UN official then called for an investigation into the reports and "for the perpetrators to be held accountable."
The United Nations Secretary General said on Monday he was appalled by reports of Palestinians killed and injured while seeking aid in Gaza on Sunday, and called for an independent investigation.
"It is unacceptable that Palestinians are risking their lives for food," Antonio Guterres said in a statement. The UN official then called for an investigation into the reports and "for the perpetrators to be held accountable," later adding that Israel "has clear obligations under international humanitarian law to agree to and facilitate humanitarian aid."
"There is no military solution to the conflict," Guterres concluded.
The UN official made these statements just over a week and a half after meeting with the Hostages and Missing Families Forum, where he committed to appointing a "dedicated official to coordinate the UN's response to hostage situations worldwide," the forum announced.
The US-backed aid organization Gaza Humanitarian Foundation (GHF) had denied that the IDF attacked a food distribution point near Rafah when Sunday's incident occurred. The military also denied reports of firing on civilians.
The IDF added that it closely cooperates with the GHF and international aid groups to ensure aid reaches Gaza's residents, and also bypasses going into the hands of the Hamas terrorist organization.
The military then released drone footage the same day that showed armed and masked individuals shooting at Palestinian civilians who were trying to collect aid in southern Khan Yunis.
Last Thursday, the GHF also denied reports that five Palestinians were killed following the last two days of distribution of humanitarian aid in the Gaza Strip.
"There are many parties who wish to see GHF fail," the humanitarian organization said. "Their goal is to force a return to the status quo, even if it means risking lifesaving aid to the people of Gaza."
Two days earlier, it was reported that crowds of Palestinians who arrived to retrieve aid had overrun the outer defenses of the GHF's food distribution centers. While there were no killings of civilians in the incident, the IDF and US security contractors who were running the aid distribution had to fire warning shots in the air to make the crowd back off.
Yonah Jeremy Bob contributed to this report.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dr. Reddy's and Alvotech partner to develop and commercialize Biosimilar to Keytruda
Dr. Reddy's and Alvotech partner to develop and commercialize Biosimilar to Keytruda

Business Upturn

time31 minutes ago

  • Business Upturn

Dr. Reddy's and Alvotech partner to develop and commercialize Biosimilar to Keytruda

By Aman Shukla Published on June 5, 2025, 08:41 IST Dr. Reddy's Laboratories Ltd., a leading Indian pharmaceutical company, has entered into a strategic collaboration with Alvotech, a global biotech firm specializing in biosimilar medicines. The partnership aims to co-develop, manufacture, and commercialize a biosimilar version of Keytruda® (pembrolizumab), a groundbreaking cancer treatment used for multiple cancer types worldwide. Keytruda® is a highly successful immunotherapy drug, with global sales reaching an impressive US$29.5 billion in 2024. By combining their expertise, Dr. Reddy's and Alvotech plan to accelerate the biosimilar's development timeline and expand its availability across international markets. Under the agreement, both companies will share development costs and responsibilities, ensuring efficient manufacturing and distribution. Each partner retains the right to commercialize the biosimilar globally, with certain exceptions, maximizing reach and impact. 'We are very pleased to enter into this collaboration for pembrolizumab with Dr. Reddy's. This agreement demonstrates Alvotech's ability to leverage its dedicated R&D and manufacturing platform for biosimilars, accelerating the expansion of our pipeline by pursuing growing global markets. It further enables us to increase the availability of cost-effective, critical biologic medications to patients world-wide,' said Róbert Wessman, chairman and CEO of Alvotech. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Trump Hits Columbia With Big New Threat Even After It Caved
Trump Hits Columbia With Big New Threat Even After It Caved

Yahoo

timean hour ago

  • Yahoo

Trump Hits Columbia With Big New Threat Even After It Caved

Surrender wasn't enough to spare Columbia University from Donald Trump's wrath. The Department of Education issued a new threat against Columbia Wednesday, this time targeting its accreditation. The department alleged that the elite New York City school was 'in violation of federal anti-discrimination laws' for failing to stamp out antisemitism on campus. The DOE's press release revealed that it had notified the organization responsible for ensuring that Columbia is in compliance with accreditation standards of the alleged violation. 'After Hamas' October 7, 2023, terror attack on Israel, Columbia University's leadership acted with deliberate indifference towards the harassment of Jewish students on its campus,' said Linda McMahon, Trump's education secretary. 'This is not only immoral, but also unlawful. Accreditors have an enormous public responsibility as gatekeepers of federal student aid.' The move is an escalation in Trump's war on top universities. Since March, the president's administration has frozen $400 million in federal funding to Columbia. The university acquiesced to Trump's list of demands that month—including a ban on face masks and a vow to harshly protest pro-Palestinian student protesters. Losing accreditation would strip the university of state and federal financial funding, such as Pell Grants for low-income students. It could also inflict damage to Columbia's reputation and make its undergraduates ineligible for many graduate programs. Columbia's accreditor, Middle States Commission on Higher Education (MSCHE), requires that it follow relevant laws. The Education Department is alleging that the university has violated the Civil Rights Act of 1964 by failing to 'meaningfully protect Jewish students against severe and pervasive harassment on Columbia's campus.' While the Department of Education plays a role in setting accreditation standards, the organizations that determine whether a university is following them, like the MSCHE, operate independently. The MSCHE told the Daily Beast in a statement that it had received the letter from the Education Department but declined to comment further. Columbia did not immediately return a request for comment. Last week, Trump praised Columbia's deference and said that the school had earned a reprieve from his attacks. 'You know, Columbia has been really—they were very, very bad, what they've done. They're very antisemitic and lots of other things,' he said. 'But they're working with us on finding a solution, and, you know, they're taken off that hot seat.' In the months since Columbia gave into Trump's demands, one of its peers, Harvard University, has fought a fierce legal battle to avoid following suit. Harvard's defiance has earned it an escalating series of punishments—$2.5 billion in frozen funds, a threat against its tax-exempt status, and a push to strip its ability enroll international students. Despite suffering losses in court, Trump has declared that he is winning the war. 'But Harvard wants to fight. They want to show how smart they are, and they're getting their a-- kicked,' the president said. Harvard's president, Alan Garber, has urged other colleges and universities to fight back against Trump. 'I would say that we need to be firm in our commitments to what we stand for,' he told NPR.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store